Amgen

Quality Oversight Compliance Mgr

Employer
Amgen
Location
Thousand Oaks, CA
Posted
Oct 09, 2021
Ref
R-127686
Required Education
Bachelors Degree
Position Type
Full time
Strengthen and advance Amgens R&D QMSImprove R&D processes through contribution of expertise in identifying appropriate CAPAsEnable timely completion of CAPAs throughCAPA status reportsIdentify CAPA trendsEnsure quality of data in RDCSTo support objective compliance advice and quality oversight to the business for GxP activities, including the intake, analysis and investigation of adverse events and product complaints/integrated events across the Amgen portfolio
Join Us

If you're seeking a career where you can truly make a difference in the lives of others, a career where you can work at the absolute forefront of biotechnology with the top minds in the field, you'll find it at Amgen.

Amgen, a biotechnology pioneer, discovers, develops and delivers innovative human therapeutics. Our medicines have helped millions of patients in the fight against cancer, kidney disease, rheumatoid arthritis and other serious illnesses.

As an organization dedicated to improving the quality of life for people around the world, Amgen fosters an inclusive environment of diverse, ethical, committed and highly accomplished people who respect each other but compete intensely to win. Together, we live the Amgen values as we continue advancing science to serve patients.

Amgen is an Equal Opportunity employer and will consider all qualified applicants for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, or disability status.

Amgen requires all staff in the United States and Puerto Rico to be vaccinated from COVID 19 as a condition of employment. In accordance with applicable law, Amgen will provide reasonable accommodations to staff members who qualify on the basis of a medical reason or a sincerely held religious belief, practice, or observance. Such accommodation may not pose an undue hardship to Amgen, its operations, or its staff.